Robert L. Zerbe M.D., Director at Vericel Corp (VCEL), sold 5,000 shares at $57.50 ($281K) on 2024-11-12, disclosed to the SEC on 2024-11-13.
Scheduled sale ($281k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.00 | 2,500 | $138K | 48.9% |
| 2 | $57.50 | 2,500 | $144K | 51.1% |
| Total | $56.25 avg | 5,000 | $281K | 100% |
| Filing → |
| VCEL | SELL | 2024-03-29 | $338K | — | Filing → |
| VCEL | SELL | 2024-02-22 | $36K | — | Filing → |
| VCEL | SELL | 2024-01-30 | $102K | — | Filing → |